Work

Abstract CT289: Phase Ib study of POLQ inhibitor SYN818 combined with olaparib in advanced solid tumors

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-ct289

Authors: Hongxia Wang, Xiaohua Wu, Min Yan, Jian Zhang, Youzhong Zhang, Yiqun Du, Sai Han, Xiaojun Liu, Jiajia Li, Limin Niu, Duo Wu, Yue Xie, Xuzhen Tang, Chao Kan, Song Shi, Hu He, Song Liu, Xiaochun Yu

Institutions: Fudan University Shanghai Cancer Center, Zhengzhou University, Henan Cancer Hospital, Qilu Hospital of Shandong University

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154699672

Cites:

Cited by:

Related to: